| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.43 | 0.0004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |